Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	NTx®-265 Low Dose
Total, all-cause mortality	NTx®-265 Medium Dose
Total, all-cause mortality	NTx®-265 High Dose
Total, all-cause mortality	Saline Placebo
Total, other adverse events	NTx®-265 Low Dose	9	24
Total, other adverse events	NTx®-265 Medium Dose	19	24
Total, other adverse events	NTx®-265 High Dose	2	24
Total, other adverse events	Saline Placebo	10	24
Total, serious adverse events	NTx®-265 Low Dose	2	24
Total, serious adverse events	NTx®-265 Medium Dose	4	24
Total, serious adverse events	NTx®-265 High Dose	3	24
Total, serious adverse events	Saline Placebo	2	24

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00938314/event-totals